{"pmid":32340562,"title":"A Molecular Modeling Approach to Identify Effective Antiviral Phytochemicals against the Main Protease of SARS-CoV-2.","text":["A Molecular Modeling Approach to Identify Effective Antiviral Phytochemicals against the Main Protease of SARS-CoV-2.","The main protease of SARS-CoV-2 is one of the important targets to design and develop antiviral drugs. In this study, we have selected 40 antiviral phytochemicals to find out the best candidates which can act as potent inhibitors against the main protease. Molecular docking is performed using AutoDock Vina and GOLD suite to determine the binding affinities and interactions between the phytochemicals and the main protease. The selected candidates strongly interact with the key Cys145 and His41 residues. To validate the docking interactions, 100 ns molecular dynamics (MD) simulations on the five top-ranked inhibitors including hypericin, cyanidin 3-glucoside, baicalin, glabridin, and alpha-ketoamide-11r were performed. Principal component analysis (PCA) of potential energy components of MD discloses that baicalin, cyanidin 3-glucoside, and alpha-ketoamide-11r have structural similarity with the apo-form of the main protease. These findings are also strongly supported by root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), and solvent accessible surface area (SASA) investigations. PCA is also used to find out the quantitative structure-activity relationship (QSAR) for pattern recognition of the best ligands. Multiple linear regression (MLR) of QSAR reveals the R(2) value of 0.842 for the training set and 0.753 for the test set. Our proposed MLR model can predict the favorable binding energy compared with the binding energy detected from molecular docking. ADMET analysis demonstrates that these candidates appear to be safer inhibitors. Our comprehensive computational and statistical analysis show that these selected phytochemicals can be used as potential inhibitors against the SARS-CoV-2.","J Biomol Struct Dyn","Islam, Rajib","Parves, Rimon","Paul, Archi Sundar","Uddin, Nizam","Rahman, Md Sajjadur","Mamun, Abdulla Al","Hossain, Md Nayeem","Ali, Md Ackas","Halim, Mohammad A","32340562"],"abstract":["The main protease of SARS-CoV-2 is one of the important targets to design and develop antiviral drugs. In this study, we have selected 40 antiviral phytochemicals to find out the best candidates which can act as potent inhibitors against the main protease. Molecular docking is performed using AutoDock Vina and GOLD suite to determine the binding affinities and interactions between the phytochemicals and the main protease. The selected candidates strongly interact with the key Cys145 and His41 residues. To validate the docking interactions, 100 ns molecular dynamics (MD) simulations on the five top-ranked inhibitors including hypericin, cyanidin 3-glucoside, baicalin, glabridin, and alpha-ketoamide-11r were performed. Principal component analysis (PCA) of potential energy components of MD discloses that baicalin, cyanidin 3-glucoside, and alpha-ketoamide-11r have structural similarity with the apo-form of the main protease. These findings are also strongly supported by root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), and solvent accessible surface area (SASA) investigations. PCA is also used to find out the quantitative structure-activity relationship (QSAR) for pattern recognition of the best ligands. Multiple linear regression (MLR) of QSAR reveals the R(2) value of 0.842 for the training set and 0.753 for the test set. Our proposed MLR model can predict the favorable binding energy compared with the binding energy detected from molecular docking. ADMET analysis demonstrates that these candidates appear to be safer inhibitors. Our comprehensive computational and statistical analysis show that these selected phytochemicals can be used as potential inhibitors against the SARS-CoV-2."],"journal":"J Biomol Struct Dyn","authors":["Islam, Rajib","Parves, Rimon","Paul, Archi Sundar","Uddin, Nizam","Rahman, Md Sajjadur","Mamun, Abdulla Al","Hossain, Md Nayeem","Ali, Md Ackas","Halim, Mohammad A"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340562","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/07391102.2020.1761883","keywords":["antiviral phytochemicals","covid-19","sars-cov-2","molecular docking","molecular dynamics"],"locations":["hypericin","cyanidin","QSAR"],"e_drugs":["hypericin","glabridin","baicalin","cyanidin 3-O-glucoside"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138495136038914,"score":9.490897,"similar":[{"pmid":32410504,"title":"Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2. A molecular dynamic study.","text":["Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2. A molecular dynamic study.","Sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA (ssRNA) virus, responsible for severe acute respiratory disease (COVID-19). A large number of natural compounds are under trial for screening compounds, possessing potential inhibitory effect against the viral infection. Keeping in view the importance of marine compounds in antiviral activity, we investigated the potency of some marine natural products to target SARS-CoV-2 main protease (M(pro)) (PDB ID 6MO3). The crystallographic structure of M(pro) in an apo form was retrieved from Protein Data Bank and marine compounds from PubChem. These structures were prepared for docking and the complex with good docking score was subjected to molecular dynamic (MD) simulations for a period of 100ns. To measure the stability, flexibility, and average distance between the target and compounds, root means square deviations (RMSD), root means square fluctuation (RMSF), and the distance matrix were calculated. Among five marine compounds, C-1 (PubChem CID 11170714) exhibited good activity, interacting with the active site and surrounding residues, forming many hydrogen and hydrophobic interactions. The C-1 also attained a stable dynamic behavior, and the average distance between compound and target remains constant. In conclusion, marine natural compounds may be used as a potential inhibitor against SARS-CoV-2 for better management of COVID-19.","J Biomol Struct Dyn","Khan, Muhammad Tahir","Ali, Arif","Wang, Qiankun","Irfan, Muhammad","Khan, Abbas","Zeb, Muhammad Tariq","Zhang, Yu-Juan","Chinnasamy, Sathishkumar","Wei, Dong-Qing","32410504"],"abstract":["Sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA (ssRNA) virus, responsible for severe acute respiratory disease (COVID-19). A large number of natural compounds are under trial for screening compounds, possessing potential inhibitory effect against the viral infection. Keeping in view the importance of marine compounds in antiviral activity, we investigated the potency of some marine natural products to target SARS-CoV-2 main protease (M(pro)) (PDB ID 6MO3). The crystallographic structure of M(pro) in an apo form was retrieved from Protein Data Bank and marine compounds from PubChem. These structures were prepared for docking and the complex with good docking score was subjected to molecular dynamic (MD) simulations for a period of 100ns. To measure the stability, flexibility, and average distance between the target and compounds, root means square deviations (RMSD), root means square fluctuation (RMSF), and the distance matrix were calculated. Among five marine compounds, C-1 (PubChem CID 11170714) exhibited good activity, interacting with the active site and surrounding residues, forming many hydrogen and hydrophobic interactions. The C-1 also attained a stable dynamic behavior, and the average distance between compound and target remains constant. In conclusion, marine natural compounds may be used as a potential inhibitor against SARS-CoV-2 for better management of COVID-19."],"journal":"J Biomol Struct Dyn","authors":["Khan, Muhammad Tahir","Ali, Arif","Wang, Qiankun","Irfan, Muhammad","Khan, Abbas","Zeb, Muhammad Tariq","Zhang, Yu-Juan","Chinnasamy, Sathishkumar","Wei, Dong-Qing"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410504","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/07391102.2020.1769733","keywords":["covid-19","dock","interactions","marine drugs"],"e_drugs":["Carbon"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666897319071580161,"score":534.9098},{"pmid":32450166,"title":"Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach.","text":["Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach.","A new SARS coronavirus (SARS-CoV-2) belonging to the genus Betacoronavirus has caused a pandemic known as COVID-19. Among coronaviruses, the main protease (M(pro)) is an essential drug target which, along with papain-like proteases catalyzes the processing of polyproteins translated from viral RNA and recognizes specific cleavage sites. There are no human proteases with similar cleavage specificity and therefore, inhibitors are highly likely to be nontoxic. Therefore, targeting the SARS-CoV-2 M(pro) enzyme with small molecules can block viral replication. The present study is aimed at the identification of promising lead molecules for SARS-CoV-2 M(pro) enzyme through virtual screening of antiviral compounds from plants. The binding affinity of selected small drug-like molecules to SARS-CoV-2 M(pro), SARS-CoV M(pro) and MERS-CoV M(pro) were studied using molecular docking. Bonducellpin D was identified as the best lead molecule which shows higher binding affinity (-9.28kcal/mol) as compared to the control (-8.24kcal/mol). The molecular binding was stabilized through four hydrogen bonds with Glu166 and Thr190 as well as hydrophobic interactions via eight residues. The SARS-CoV-2 M(pro) shows identities of 96.08% and 50.65% to that of SARS-CoV M(pro) and MERS-CoV M(pro) respectively at the sequence level. At the structural level, the root mean square deviation (RMSD) between SARS-CoV-2 M(pro) and SARS-CoV M(pro) was found to be 0.517A and 0.817A between SARS-CoV-2 M(pro) and MERS-CoV M(pro). Bonducellpin D exhibited broad-spectrum inhibition potential against SARS-CoV M(pro) and MERS-CoV M(pro) and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies.","Life Sci","Gurung, Arun Bahadur","Ali, Mohammad Ajmal","Lee, Joongku","Farah, Mohammad Abul","Al-Anazi, Khalid Mashay","32450166"],"abstract":["A new SARS coronavirus (SARS-CoV-2) belonging to the genus Betacoronavirus has caused a pandemic known as COVID-19. Among coronaviruses, the main protease (M(pro)) is an essential drug target which, along with papain-like proteases catalyzes the processing of polyproteins translated from viral RNA and recognizes specific cleavage sites. There are no human proteases with similar cleavage specificity and therefore, inhibitors are highly likely to be nontoxic. Therefore, targeting the SARS-CoV-2 M(pro) enzyme with small molecules can block viral replication. The present study is aimed at the identification of promising lead molecules for SARS-CoV-2 M(pro) enzyme through virtual screening of antiviral compounds from plants. The binding affinity of selected small drug-like molecules to SARS-CoV-2 M(pro), SARS-CoV M(pro) and MERS-CoV M(pro) were studied using molecular docking. Bonducellpin D was identified as the best lead molecule which shows higher binding affinity (-9.28kcal/mol) as compared to the control (-8.24kcal/mol). The molecular binding was stabilized through four hydrogen bonds with Glu166 and Thr190 as well as hydrophobic interactions via eight residues. The SARS-CoV-2 M(pro) shows identities of 96.08% and 50.65% to that of SARS-CoV M(pro) and MERS-CoV M(pro) respectively at the sequence level. At the structural level, the root mean square deviation (RMSD) between SARS-CoV-2 M(pro) and SARS-CoV M(pro) was found to be 0.517A and 0.817A between SARS-CoV-2 M(pro) and MERS-CoV M(pro). Bonducellpin D exhibited broad-spectrum inhibition potential against SARS-CoV M(pro) and MERS-CoV M(pro) and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies."],"journal":"Life Sci","authors":["Gurung, Arun Bahadur","Ali, Mohammad Ajmal","Lee, Joongku","Farah, Mohammad Abul","Al-Anazi, Khalid Mashay"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32450166","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.lfs.2020.117831","keywords":["antiviral properties","binding affinity","covid-19","medicinal plants","molecular docking","phytochemicals","sars-cov-2","sars-cov-2 m(pro)"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213978083331,"score":456.4366},{"pmid":32448034,"title":"Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.","text":["Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel corona virus that causes corona virus disease 2019 (COVID-19). The COVID-19 rapidly spread across the nations with high mortality rate even as very little is known to contain the virus at present. In the current study, we report novel natural metabolites namely, ursolic acid, carvacrol and oleanolic acid as the potential inhibitors against main protease (M(pro)) of COVID-19 by using integrated molecular modeling approaches. From a combination of molecular docking and molecular dynamic (MD) simulations, we found three ligands bound to protease during 50 ns of MD simulations. Furthermore, the molecular mechanic/generalized/Born/Poisson-Boltzmann surface area (MM/G/P/BSA) free energy calculations showed that these chemical molecules have stable and favourable energies causing strong binding with binding site of M(pro) protein. All these three molecules, namely, ursolic acid, carvacrol and oleanolic acid, have passed the ADME (Absorption, Distribution, Metabolism, and Excretion) property as well as Lipinski's rule of five. The study provides a basic foundation and suggests that the three phytochemicals, viz. ursolic acid, carvacrol and oleanolic acid could serve as potential inhibitors in regulating the M(pro) protein's function and controlling viral replication.","J Biomol Struct Dyn","Kumar, Anuj","Choudhir, Gourav","Shukla, Sanjeev Kumar","Sharma, Mansi","Tyagi, Pankaj","Bhushan, Arvind","Rathore, Madhu","32448034"],"abstract":["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel corona virus that causes corona virus disease 2019 (COVID-19). The COVID-19 rapidly spread across the nations with high mortality rate even as very little is known to contain the virus at present. In the current study, we report novel natural metabolites namely, ursolic acid, carvacrol and oleanolic acid as the potential inhibitors against main protease (M(pro)) of COVID-19 by using integrated molecular modeling approaches. From a combination of molecular docking and molecular dynamic (MD) simulations, we found three ligands bound to protease during 50 ns of MD simulations. Furthermore, the molecular mechanic/generalized/Born/Poisson-Boltzmann surface area (MM/G/P/BSA) free energy calculations showed that these chemical molecules have stable and favourable energies causing strong binding with binding site of M(pro) protein. All these three molecules, namely, ursolic acid, carvacrol and oleanolic acid, have passed the ADME (Absorption, Distribution, Metabolism, and Excretion) property as well as Lipinski's rule of five. The study provides a basic foundation and suggests that the three phytochemicals, viz. ursolic acid, carvacrol and oleanolic acid could serve as potential inhibitors in regulating the M(pro) protein's function and controlling viral replication."],"journal":"J Biomol Struct Dyn","authors":["Kumar, Anuj","Choudhir, Gourav","Shukla, Sanjeev Kumar","Sharma, Mansi","Tyagi, Pankaj","Bhushan, Arvind","Rathore, Madhu"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448034","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/07391102.2020.1772112","keywords":["covid-19","carvacrol","oleanolic acid","protease","ursolic acid"],"e_drugs":["Oleanolic Acid","carvacrol","ursolic acid"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667785213974937600,"score":454.47253},{"pmid":32476576,"title":"Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.","text":["Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.","Coronaviruses are contagious pathogens primarily responsible for respiratory and intestinal infections. Research efforts to develop antiviral agents against coronavirus demonstrated the main protease (Mpro) protein may represent effective drug target. X-ray crystallographic structure of the SARS-CoV2 Mpro protein demonstrated the significance of Glu166, Cys141, and His41 residues involved in protein dimerization and its catalytic function. We performed in silico screening of compounds from Curcuma longa L. (Zingiberaceae family) against Mpro protein inhibition. Employing a combination of molecular docking, scoring functions, and molecular dynamics simulations, 267 compounds were screened by docking on Mpro crystallographic structure. Docking score and interaction profile analysis exhibited strong binding on the Mpro catalytic domain with compounds C1 (1E,6E)-1,2,6,7-tetrahydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3, 5-dione) and C2 (4Z,6E)-1,5-dihydroxy-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one as lead agents. Compound C1 and C2 showed minimum binding score (-9.08 and -8.07 kcal/mole) against Mpro protein in comparison to shikonin and lopinavir ( approximately -5.4 kcal/mole) a standard Mpro inhibitor. Furthermore, principal component analysis, free energy landscape and protein-ligand energy calculation studies revealed that these two compounds strongly bind to the catalytic core of the Mpro protein with higher efficacy than lopinavir, a standard antiretroviral of the protease inhibitor class. Taken together, this structure based optimization has provided lead on two natural Mpro inhibitors for further testing and development as therapeutics against human coronavirus.","J Biomol Struct Dyn","Gupta, Sanjay","Singh, Atul Kumar","Kushwaha, Prem Prakash","Prajapati, Kumari Sunita","Shuaib, Mohd","Senapati, Sabyasachi","Kumar, Shashank","32476576"],"abstract":["Coronaviruses are contagious pathogens primarily responsible for respiratory and intestinal infections. Research efforts to develop antiviral agents against coronavirus demonstrated the main protease (Mpro) protein may represent effective drug target. X-ray crystallographic structure of the SARS-CoV2 Mpro protein demonstrated the significance of Glu166, Cys141, and His41 residues involved in protein dimerization and its catalytic function. We performed in silico screening of compounds from Curcuma longa L. (Zingiberaceae family) against Mpro protein inhibition. Employing a combination of molecular docking, scoring functions, and molecular dynamics simulations, 267 compounds were screened by docking on Mpro crystallographic structure. Docking score and interaction profile analysis exhibited strong binding on the Mpro catalytic domain with compounds C1 (1E,6E)-1,2,6,7-tetrahydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3, 5-dione) and C2 (4Z,6E)-1,5-dihydroxy-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one as lead agents. Compound C1 and C2 showed minimum binding score (-9.08 and -8.07 kcal/mole) against Mpro protein in comparison to shikonin and lopinavir ( approximately -5.4 kcal/mole) a standard Mpro inhibitor. Furthermore, principal component analysis, free energy landscape and protein-ligand energy calculation studies revealed that these two compounds strongly bind to the catalytic core of the Mpro protein with higher efficacy than lopinavir, a standard antiretroviral of the protease inhibitor class. Taken together, this structure based optimization has provided lead on two natural Mpro inhibitors for further testing and development as therapeutics against human coronavirus."],"journal":"J Biomol Struct Dyn","authors":["Gupta, Sanjay","Singh, Atul Kumar","Kushwaha, Prem Prakash","Prajapati, Kumari Sunita","Shuaib, Mohd","Senapati, Sabyasachi","Kumar, Shashank"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476576","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/07391102.2020.1776157","keywords":["curcuma longa","inhibitor","md simulation","main protease","sars-cov-2"],"locations":["Curcuma"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1668437835197186050,"score":418.69388},{"pmid":32389723,"title":"Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.","text":["Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking.","In the current episode of novel coronavirus (SARS-CoV-2) spreads, antiviral drug discovery is of great importance. Auto dock vina was used to screen potential drugs by molecular docking with the structure protein and non-structure protein sites of new coronavirus. Ribavirin, a common antiviral drug, as well as remdesivir, chloroquine and luteolin, were all studied. Honeysuckle is generally believed to have antiviral effect in traditional Chinese medicine, the main flavonoid in which is Luteolin. In the study, it was found luteolin could bind to the same sites of main protease of SARS-CoV-2 as the control molecular with a high affinity. Chloroquine, was proved clinically effective, can bind to the main protease, which may be the possible antiviral mechanism. And the study was restricted to molecular docking without validation by MD simulations. Interactions with the main protease may play a key role in in fighting against viruses. Luteolin is a potential antiviral molecule worthy of attention.","Int J Antimicrob Agents","Yu, Ran","Chen, Liang","Lan, Rong","Shen, Rong","Li, Peng","32389723"],"abstract":["In the current episode of novel coronavirus (SARS-CoV-2) spreads, antiviral drug discovery is of great importance. Auto dock vina was used to screen potential drugs by molecular docking with the structure protein and non-structure protein sites of new coronavirus. Ribavirin, a common antiviral drug, as well as remdesivir, chloroquine and luteolin, were all studied. Honeysuckle is generally believed to have antiviral effect in traditional Chinese medicine, the main flavonoid in which is Luteolin. In the study, it was found luteolin could bind to the same sites of main protease of SARS-CoV-2 as the control molecular with a high affinity. Chloroquine, was proved clinically effective, can bind to the main protease, which may be the possible antiviral mechanism. And the study was restricted to molecular docking without validation by MD simulations. Interactions with the main protease may play a key role in in fighting against viruses. Luteolin is a potential antiviral molecule worthy of attention."],"journal":"Int J Antimicrob Agents","authors":["Yu, Ran","Chen, Liang","Lan, Rong","Shen, Rong","Li, Peng"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389723","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ijantimicag.2020.106012","keywords":["2019-ncov","autodock vina","chloroquine","luteolin","remdesivir","ribavirin"],"locations":["vina","Chinese","flavonoid"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Chloroquine","Luteolin","Flavonoids","Ribavirin","remdesivir"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666528580014702592,"score":418.32217}]}